CLICK TO READ!

EARLY ITCH RESPONSE WITH ABROCITINIB IS ASSOCIATED WITH LATER EFFICACY OUTCOMES IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS | DR. MATTHEW ZIRWAS

Practice Update

Effect of Upadacitinib on Atopic Hand Eczema in Patients With Moderate to Severe Atopic Dermatitis

| DR. MATTHEW ZIRWAS

Practice Update

JAMA DERMATOLOGY STUDY EVALUATES NONSTEROIDAL ROFLUMILAST FOAM FOR SEBORRHEIC DERMATITIS

May 15th 2023| DR. MATTHEW ZIRWAS

FOOD-INDUCED SKIN + MUCOSAL PRURITUS: CLINICAL CHARACTERISTICS, PATHOPHYSIOLOGY, AND RECOMMENDATIONS | MATTHEW ZIRWAS, MD

THE DERMATOLOGIST Q+A WITH DR. MATTHEW ZIRWAS | TREATING HAND ECZEMA

Amanda Balbi, Associate Director, Digital Content

FIVE TIPS YOU MIGHT ACTUALLY USE FROM AN ATOPIC DERMATITIS AND ITCH SPECIALIST | DR. MATTHEW ZIRWAS

Practice Update

PATHOPHYSIOLOGY, DISEASE PRESENTATION, AND TREATMENT STRATEGIES FOR SEBORRHEIC DERMATITIS| Featuring DR. MATTHEW ZIRWAS

Dermatology Daily Digest

We value your feedback!

CLICK + REVIEW BDR!

Page updated

Google Sites

Report abuse